Hormone drugs boost ovarian cancer risk

Hormone drugs boost ovarian cancer risk

(WVUE) - Women who use hormone therapy after menopause, even for just a few years, may have an increased risk of ovarian cancer.

Researchers pooled the results of 52 studies that included more than 12,000 women with ovarian cancer.

About half of those patients used hormone replacement therapy.

Researchers found when women used hormone replacement therapy for less than five years after menopause, their ovarian cancer risk increased by about 40 percent.

Study authors say the fact alone that there is an increased ovarian cancer risk should not impact treatment decisions.

They add, if women undergo this treatment they should do it at the lowest dose possible for the shortest time periods.

Findings appear in "The Lancet" medical journal.

Copyright 2015 WVUE. All rights reserved.